Programs of the Hematology/Oncology Division

Bone Marrow Transplant

 

The BMT program is under the direction of Dr. Anand Jillella. Both allogeneic and autologous stem cell transplants are offered for the treatment of hematologic malignancies (acute leukemias, chronic myelogenous leukemia, lymphomas, multiple myeloma).

The program will be expanding to perform matched unrelated donor (MUD) and mismatched stem cell transplants and to cover non-malignant hematologic disorders. Active research programs include novel approaches to myeloma and AML .

Oncology Clinical Trials

 

The division is involved in numerous clinical trials and participates in both the cooperative studies (NSABP and ECOG) and pharmaceutical sponsored trials.

The oncology clinical trials program is under the direction of Dr. Anand Jillella, Division Director, and has been very active, particularly in the areas of breast and lung cancer.

Fellows are encouraged to have first-hand experience in the conductance of Phase II/III clinical trials. A Minority based Community Clinical Oncology Program has been funded by the National Cancer Institute

Sickle Cell Center

 

The Sickle Cell Center has a large pediatric and adult clinical program and a hemoglobinopathy reference laboratory. The Center, under the direction of Dr. Abdullah Kutlar, is involved in many clinical studies.

The laboratory provides reference testing for hemoglobinopathies for the State of Georgia as well as for many institutions in the country and serves as the core laboratory for several multicenter trials. It makes uses of state-of-the art methods including genetic methods in the diagnosis of hemoglobinopathies and identification of new mutations.

The center’s current research interests are on genetic modifiers of the clinical phenotype in sickle cell disease. An elective in the sickle cell program is offered to the fellows and fellows are encouraged to participate in the center’s ongoing research activities.

Hemophilia Program

 

The Hemophilia Program follows approximately 100 patients with inherited bleeding disorders (hemophilia and von Willebrand disease) in the area and is under the direction of Dr. Charles Lutcher and Dr. Kavita Natarajan.

It offers comprehensive services to the patients including education and social work. Fellows can do electives in the hemophilia/coag program